Bayer Aktiengesellschaft is trading at €33.30 (-5.21%) after news of a fresh legal obstacle in the company's long-running Roundup weedkiller litigation renewed investor uncertainty.
- Plaintiffs are seeking to transfer the proposed $7.25 billion U.S. settlement to a federal court in California.
- The move has sparked concern as the case could now be overseen by a judge who has previously been critical of Bayer's settlement strategy, potentially jeopardizing the deal.
- Bayer has stated it will oppose the transfer of the case, which was intended to resolve current and future claims alleging its Roundup product causes cancer.